Regeneron Pharmaceuticals (REGN) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter increased compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter increased compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$3.4B
Revenue reported for this quarter.
Quarter-over-quarter
+6.5%
Change from the immediately preceding quarter.
Year-over-year
+14.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$13.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $3.4B | -31.0% |
| Mar 31, 2023 | $3.2B | +6.6% |
| Jun 30, 2023 | $3.2B | +10.5% |
| Sep 30, 2023 | $3.4B | +14.5% |
Revenue performance
The reported revenue direction is upward for the current quarter.
Quarterly comparison
Revenue was higher than the immediately preceding quarter. Revenue was also higher than the same quarter one year ago.
What to watch
No filing context is provided to identify specific factors affecting revenue.